Improve Care and Save Clinician Time by Streamlining Specialty Drug PrescribingSign Up Now
Tuesday October 24, 2017
1 PM Eastern, 12 PM Central, 10 AM Pacific
Clinicians who treat complex pulmonary conditions, as well as other conditions requiring specialty drugs spend extra time each week initiating prescription orders and completing prior authorization paperwork. This webinar will describe how Arizona Pulmonary Specialists automated the inefficient specialty drug ordering process to improve patient care while saving its clinicians time.
This webinar is geared toward medical directors, physicians, and clinicians who treat patients with complex conditions that require specialty drugs.
Attendees of this webinar will be able to:
1) Describe the inefficiencies associated with the traditional specialty drug prescribing process.
2) List the benefits associated with adopting new technology to automate the specialty drug prescribing workflow.
3) Explain the typical implementation process for automating specialty drug prescribing.
4) Identify how new technology solutions for automating specialty prescribing can help practices better serve patients.
Jeremy Feldman, MD Director of the Pulmonary Hypertension and Advanced Lung Disease Program and Medical Director of Research at Arizona Pulmonary Specialists.
Jeremy Feldman, MD, earned his bachelors of science with distinction in biology from Stanford University in 1994. From 1994-1998 he attended UCSD school of medicine where he was the Medicine, Education and Research Foundation Scholarship recipient. After graduating medical school, Dr. Feldman trained in Internal Medicine at Harvard University’s Brigham and Women’s Hospital. From there he went to University of California at San Francisco for pulmonary and critical care training. He then moved south to Stanford University to take on the eBay fellowship in Pulmonary Vascular Disease.
After completing his training, Dr. Feldman moved to Phoenix and joined Arizona Pulmonary Specialists.
He is active in critical care and the management of patients with advanced lung disease. His research interests include pulmonary hypertension and interstitial lung disease. He has developed leading educational websites for pulmonary hypertension and pulmonary fibrosis.
Karen Tirozzi, VP of Solutions at ZappRx
At ZappRx, Karen forges strategic partnerships with technology and specialty pharmacy companies who can enhance ZappRx’s capabilities, as well as oversees the deployment of their technology to their healthcare provider customers.